Talaris Therapeutics to Present at the 11th Annual SVB Leerink Global Healthcare Conference

Rhea-AI Summary

Talaris Therapeutics (Nasdaq: TALS), a late-clinical stage cell therapy company, will have its CEO Scott Requadt present at the 11th Annual SVB Leerink Global Healthcare Conference on February 18, 2022, at 8:40 AM ET. The presentation will focus on therapies aimed at transforming the standard of care in solid organ transplantation and severe immune and blood disorders. A live webcast of this event will be available on Talaris’ website, with an archive accessible for 30 days post-event.

BOSTON and LOUISVILLE, Ky., Feb. 11, 2022 (GLOBE NEWSWIRE) -- Talaris Therapeutics, Inc. (Nasdaq: TALS), a late-clinical stage cell therapy company developing therapies with the potential to transform the standard of care in solid organ transplantation and severe immune and blood disorders, today announced that Scott Requadt, Chief Executive Officer of Talaris, will present in a fireside chat at the 11th Annual SVB Leerink Global Healthcare Conference on Friday, February 18, 2022 at 8:40 AM ET.

A live webcast of the fireside chat will be available on the investors section of the Talaris website at www.talaristx.com. After the live webcast, the event will remain archived on the Talaris website for 30 days.

About Talaris Therapeutics
Talaris Therapeutics, Inc. is a late-clinical stage cell therapy company developing therapies with the potential to transform the standard of care in solid organ transplantation and severe immune and blood disorders. Talaris maintains corporate offices in Boston, MA, its cell processing facility in Louisville, KY, and additional research operations in Houston, TX.

Media Contact
Marin Bergman
Ten Bridge Communications
marin@tenbridgecommunications.com
(818) 516-2746

Investor Contact
Chris Brinzey
ICR Westwicke
chris.brinzey@westwicke.com 
(339) 970-2843

 

FAQ

What is Talaris Therapeutics presenting at the SVB Leerink Global Healthcare Conference?

Talaris Therapeutics will have its CEO Scott Requadt presenting on therapies for solid organ transplantation and immune disorders.

When is Talaris Therapeutics' presentation at the conference?

The presentation is scheduled for February 18, 2022, at 8:40 AM ET.

Where can I watch the Talaris Therapeutics presentation?

The presentation can be watched live on Talaris' website, and the archive will be available for 30 days.

What is the ticker symbol for Talaris Therapeutics?

The ticker symbol for Talaris Therapeutics is TALS.

What is the focus of Talaris Therapeutics' research?

Talaris Therapeutics focuses on cell therapies for solid organ transplantation and severe immune and blood disorders.